Exo Imaging Ultrasound System
Portable, AI-powered ultrasound imaging system for point-of-care diagnostics
Company profile
Company profile
Exo Imaging is a medical technology company focused on democratizing access to ultrasound imaging through innovative, portable devices powered by artificial intelligence. The company has developed a handheld ultrasound system that aims to make diagnostic imaging more accessible, affordable, and user-friendly for healthcare providers across diverse clinical environments. By combining advanced ultrasound technology with AI-driven image optimization and interpretation support, Exo Imaging enables clinicians to perform high-quality diagnostic imaging at the point of care. Their solution is designed to address the limitations of traditional ultrasound systems, which are often expensive, bulky, and require specialized training to operate effectively. The company's technology serves healthcare providers in hospitals, clinics, emergency departments, and remote or resource-limited settings where access to traditional imaging equipment may be constrained. Exo Imaging's approach focuses on simplifying the ultrasound workflow while maintaining diagnostic quality, potentially expanding the use of ultrasound imaging to more clinical scenarios and enabling earlier detection and diagnosis of medical conditions.
Company description Exo Imaging official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Embedded deployment with recorded integration context.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Portable, AI-powered ultrasound imaging system for point-of-care diagnostics
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Diagnostics (Basel, Switzerland) · Aug 25, 2025
Overcoming barriers in the use of artificial intelligence in point of care ultrasound.NPJ digital medicine · Apr 19, 2025
Enhancing Lung Ultrasound Diagnostics: A Clinical Study on an Artificial Intelligence Tool for the Detection and Quantification of A-Lines and B-Lines.Diagnostics (Basel, Switzerland) · Nov 12, 2024
Assessment of an Artificial Intelligence Tool for Estimating Left Ventricular Ejection Fraction in Echocardiograms from Apical and Parasternal Long-Axis Views.Diagnostics (Basel, Switzerland) · Aug 8, 2024
ACU2E-Net: A novel predict-refine attention network for segmentation of soft-tissue structures in ultrasound images.Computers in biology and medicine · May 1, 2023
Clinical validation
No linked records are currently available.
Regulatory
K260217 · 510k · Feb 24, 2026
AI Platform 2.0 (AIP002)K240953 · 510k · Aug 5, 2024
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Exo Imaging's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.